Icatibant Acetate | Interleukin Related interleukin-related.com

Product Name :
Icatibant Acetate

Search keywords :
BDKRB2

drugId :
null

Target Vo:
Bradykinin B2 receptor

Target Vo Short Name :
BKR2

Moa_Name:
Bradykinin B2 receptor antagonists

First Approval Country :
EU

First Approval Date Filter:
2008

Origin Company_Name :
Shire Development Llc

Active Company_Name :
Queen’S University Belfast

Active Indication_Name:
Angioedemas, Hereditary

In Active Indication_Name:
Joint Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NF-KB p65 Rabbit mAb custom synthesis
Anti-Mouse PD-1 Antibody (RMP1-14) References
MAP2 Antibody: MAP2 Antibody is an unconjugated, approximately 60 kDa, rabbit-derived, anti-MAP2 polyclonal antibody. MAP2 Antibody can be used for: WB, IF-Cell, IHC-P expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts